New York, NY · Founded 2014 · Privately Held (backing)
Developer of clinical nutritional products designed to assist people in healing and living a quality life. Mend (Pharmaceuticals and Biotechnology) is based in New York, NY and was founded in 2014. Its last reported valuation was $115 million in Feb 2026. It has raised $36.2 million.
Last reported valuation
$115.0M
Oct 2026
Priced at
—
Total raised
$36.2M
Last round
—
Team — not yet on record
No current team members for Mend (Pharmaceuticals and Biotechnology) are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mend (Pharmaceuticals and Biotechnology) with a free account
·The complete investor list: 16 names
·Watch Mend (Pharmaceuticals and Biotechnology): the Monday email on marks, rounds and moves
